STAT+: Practice-changing results reported for Revolution Medicines pancreatic cancer drug

Summary: A new pill for pancreatic cancer is making doctors cry happy tears. Dr. Rachna Shroff, a cancer doctor in Arizona, was amazed by the results of a new drug called daraxonrasib. Patients who took this pill lived almost twice as long as those who got regular chemotherapy. This is a huge deal because results like this have never been seen before for this type of cancer. The company that makes the drug, Revolution Medicines, shared these exciting findings at a big medical meeting and in a famous medical journal.

For more details, see statnews at statnews.com/2026/05/31/pancreatic-cancer-daraxonrasib-revolution-medicines-results-asco-2026/?utm_campaign=rss (opens in new tab)